Spectrum Pharmaceuticals, Inc. to Present Corporate Update at the Leerink Swann and Company 2013 Global Healthcare Conference in New York on February 14th

Published: Feb 07, 2013

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Leerink Swann 2013 Global Healthcare Conference being held at The Waldorf=Astoria Hotel in New York City. The Company presentation is on Thursday, February 14, 2013, at 2:00 PM ET.

Back to news